New supplement trial aims to ease the hidden struggles of schizophrenia
NCT ID NCT07393464
Summary
This study is testing if adding a dietary supplement called Pyrroloquinoline quinone (PQQ) to standard medication can help people with chronic schizophrenia. It will see if PQQ can reduce hard-to-treat symptoms like lack of motivation and improve problems with memory and thinking. About 70 participants will be randomly assigned to take either PQQ or a placebo pill for comparison, and their symptoms and brain activity will be tracked.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.